InveniAI Appoints Industry Veteran Dr. Amit Agrawal to Board of Directors and Expands Its Operations into the EU

InveniAI Establishes Presence in Basel, Switzerland as It Expands into Major Industries in Addition to Biopharma.

InveniAI Corporation, a global leader pioneering the application of artificial intelligence (AI) and machine learning (ML) to transform innovation across healthcare and other industries, announced it has appointed Amit Agrawal, Ph.D., Global Head of Portfolio Strategy and Management for Global Drug Development (GDD), Novartis as a key member of its board of directors. InveniAI has also established a European headquarters in Basel, Switzerland as the company’s platform, AlphaMeld, continues to see rapid adoption in the US and internationally.

Read More: Smart Data Solutions are the Future of the Agriculture Supply Chain Says Proagrica’s New Report

“Amit will add a broad corporate strategy perspective and bring strong biopharma experience to our board as we look to forge new partnerships,” said Krishnan Nandabalan, Ph.D., President and CEO, InveniAI Corp. “Our expansion into the EU marks a milestone moment in the growth of InveniAI as we see our platform being deployed to access and monitor innovation by world-class organizations across the globe,” he added.

Read More: DataRobot Named A Leader in Automation-Focused Machine Learning by Independent Research Firm

“InveniAI’s AI-based platform, AlphaMeld^™, accelerates identification of the next breakthrough, lending competitive advantage to its users. It can aid decision making across the entire value chain and it bridges the gap between human expertise and the insights hidden in the vast amounts of data being generated both within an organization and in the public domain,” said Amit Agrawal, Ph.D., Global Head of Portfolio Strategy and Management, GDD, Novartis. “Having seen first-hand the impact of AlphaMeld^™ in bringing new innovation to the market, I am excited to be part of their journey. InveniAI has highly curated, proprietary, large data sets that are constantly updated, unique machine learning algorithms, and a team of talented, motivated experts with several decades of domain experience in life sciences and adjacent industries.”

Read More: CryptoCasino.com Launches on the FunFair Blockchain Platform